“Secondary”的搜索结果，显示 21-30 项，共有 905 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The secondary objectives are to evaluate the efficacy of SX-682 in combination with pembrolizumab on the basis of the objective response rate, the duration ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

8. 放射肿瘤科- 临床试验- 妙佑医疗国际

   The secondary objectives of the study is to compare the overall survival (OS) of high-risk CSCC patients treated with adjuvant cemiplimab, versus those ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...